{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:21:37Z","timestamp":1770070897069,"version":"3.49.0"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"AstraZeneca"},{"name":"DOD | Defense Advanced Research Projects Agency","award":["HR011-18-3-001"],"award-info":[{"award-number":["HR011-18-3-001"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2022,10,26]]},"abstract":"<jats:p>\n            SARS-CoV-2 variants harbor multiple substitutions in their spike trimers, potentially leading to breakthrough infections and clinical resistance to immune therapies. For this reason, a BLI assay was developed and qualified to evaluate the reliability of screening SARS-CoV-2 spike trimer variants against anti-SARS-CoV-2 monoclonal antibodies (MAbs) tixagevimab and cilgavimab, the components of AZD7442, prior to\n            <jats:italic>in vitro<\/jats:italic>\n            pseudovirus neutralization susceptibility verification testing.\n          <\/jats:p>","DOI":"10.1128\/spectrum.01034-22","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T13:01:27Z","timestamp":1661173287000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":6,"title":["Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance Monitoring"],"prefix":"10.1128","volume":"10","author":[{"given":"Tyler","family":"Brady","sequence":"first","affiliation":[{"name":"Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Data Sciences and Quantitative Biology, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Tuffy","sequence":"additional","affiliation":[{"name":"Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nantaporn","family":"Haskins","sequence":"additional","affiliation":[{"name":"Biologics Engineering, R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Du","sequence":"additional","affiliation":[{"name":"Biologics Engineering, R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Lin","sequence":"additional","affiliation":[{"name":"Biologics Engineering, R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilad","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Biologics Engineering, R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Novick","sequence":"additional","affiliation":[{"name":"Data Sciences and Quantitative Biology, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany L.","family":"Roe","sequence":"additional","affiliation":[{"name":"Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuishu","family":"Ren","sequence":"additional","affiliation":[{"name":"Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"McTamney","sequence":"additional","affiliation":[{"name":"Virology and Vaccine Discovery, Vaccines and Immune Therapies, BioPharmaceuticals R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6505-7281","authenticated-orcid":true,"given":"Michael E.","family":"Abram","sequence":"additional","affiliation":[{"name":"Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Streicher","sequence":"additional","affiliation":[{"name":"Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6988-8576","authenticated-orcid":true,"given":"Elizabeth J.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&amp;D, AstraZeneca, Gaithersburg, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30484-9"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-03874-z"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-0485-4"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe5575"},{"key":"e_1_3_3_7_2","unstructured":"AstraZeneca. 2020. Phase III double-blind placebo-controlled study of AZD7442 for pre-exposure prophylaxis of COVID-19 in adult (PROVENT). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04625725. Accessed 6 July 2021."},{"key":"e_1_3_3_8_2","unstructured":"AstraZeneca. 2021. Phase III study of AZD7442 for treatment of COVID-19 in outpatient adults (TACKLE). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04723394. Accessed 1 February 2022."},{"key":"e_1_3_3_9_2","unstructured":"University of Minnesota. 2020. ACTIV-3: therapeutics for inpatients with COVID-19 (TICO). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04501978. Accessed 20 July 2021."},{"key":"e_1_3_3_10_2","unstructured":"Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale. 2020. Trial of treatments for COVID-19 in hospitalized adults (DisCoVeRy). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04315948. Accessed 20 July 2021."},{"key":"e_1_3_3_11_2","unstructured":"AstraZeneca. 2020. Phase III double-blind placebo-controlled study of AZD7442 for post-exposure prophylaxis of COVID-19 in adults (STORM CHASER). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04625972. Accessed 1 February 2022."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2548-6"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-021-00972-2"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.30.21262666"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01377-8"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31604-4"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01294-w"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01413-7"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2014.02.010"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.03.055"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.02.033"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.02.037"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03398-2"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03720-y"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12060684"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd0826"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1707304114"},{"key":"e_1_3_3_28_2","unstructured":"ICH Expert Working Group. 1994. ICH Harmonised Tripartite Guideline. Validation of analytical procedures: text and methodology Q2(R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. https:\/\/database.ich.org\/sites\/default\/files\/Q2%28R1%29%20Guideline.pdf."},{"key":"e_1_3_3_29_2","unstructured":"Food and Drug Administration. 9 February 2021. Coronavirus (COVID-19) update: FDA authorizes monoclonal antibodies for treatment of COVID-19. https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibodies-treatment-covid-19-0. Accessed 16 June 2021."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4044"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1212371109"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2021.104986"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1389"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2005.04.049"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-021-00623-0"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf1555"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.1c07965"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl6251"},{"key":"e_1_3_3_40_2","unstructured":"Sartorius. 2019. Octet BLI quantitation assays: method development guideline. https:\/\/www.sartorius.com.cn\/download\/585680\/octet-kinetics-assay-method-development-guideline-technical-note-en-sartorius-data.pdf. Accessed 29 November 2021."},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800323"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.01034-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.01034-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T13:46:04Z","timestamp":1666791964000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.01034-22"}},"subtitle":[],"editor":[{"given":"Anne","family":"Piantadosi","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10,26]]}},"alternative-id":["10.1128\/spectrum.01034-22"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.01034-22","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"2022-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01034-22"}}